𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P.2.c.011 An open study of quietiapine augmentation in treatment resistant depression

✍ Scribed by I. Anderson; A. Sarsfield; P. Haddad

Book ID
118594899
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
68 KB
Volume
18
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Olanzapine augmentation of milnacipran f
Olanzapine augmentation of milnacipran for stage 2 treatment-resistant major depression: an open study
✍ Shuken Boku; Takeshi Inoue; Hiroshi Honma; Shigehiro Matsubara; Shin Nakagawa; T πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Objective Olanzapine augmentation of fluoxetine, a selective serotonin reuptake inhibitor, is an effective augmentation therapy for treatment‐resistant depression (TRD). However, studies of olanzapine augmentation of other antidepressants are few. We investigated the efficacy and safety of olanz

Thyroxine Augmentation of Fluoxetine Tre
Thyroxine Augmentation of Fluoxetine Treatment for Resistant Depression in the Elderly: An Open Trial
✍ YORAM BARAK; DANIEL STEIN; JOSEPH LEVINE; ALIZA RING; JACK HADJEZ; AVNER ELIZUR; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 415 KB πŸ‘ 2 views

Drug resistant depression is a confounding entity. More so in populations of elderly depressives where addition of lithium or antidepressant combinations are possibly hazardous. We present an open-trial of thyroxine in elderly patients diagnosed as suffering from resistant depression. Methods -Thyro